Amgen, Inc. (AMGN)
379.33
-5.00
(-1.30%)
USD |
NASDAQ |
Feb 26, 16:00
379.00
-0.33
(-0.09%)
After-Hours: 20:00
Amgen Free Cash Flow : 8.10B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Eli Lilly & Co. | 5.964B |
| Merck & Co., Inc. | 12.36B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.603B |
| Cash from Investing (Quarterly) | -693.00M |
| Cash from Financing (Quarterly) | -1.226B |
| Free Cash Flow Per Share (Quarterly) | 1.770 |
| Free Cash Flow to Equity (Quarterly) | 113.00M |
| Free Cash Flow to Firm (Quarterly) | 1.536B |
| Free Cash Flow Yield | 3.94% |